Understanding disruptions in cancer care to reduce increased cancer burden

Introduction

The COVID-19 pandemic abruptly upended cancer care in many countries including the US. The need to reduce community spread and reserve hospital capacity for the most severe COVID-19 cases led to rescheduling or postponement of cancer care appointments.^1-5 These control measures significantly decreased cancer-related patient encounters in the early phase of the pandemic, particularly for cancer screenings.² Comparing March to July 2020 with the same period in 2019, there was a substantial decrease in cancer screenings, biopsies, surgeries, office visits, and therapy; the decreases varied by service location and cancer type.² For example, breast cancer screenings decreased by 89.2% and colorectal by 84.5%.⁶ Patients reported delays in receiving cancer care, including follow-up clinic appointments and cancer therapies, such as radiation, infusion therapies, and surgeries.^7,8

Cancer care delays due to the COVID-19 pandemic are anticipated to lead to increased cancer morbidity and mortality.^9,10 One study found an association between surgical and screening delays and increased cancer mortality among patients diagnosed with colorectal, lung, and prostate cancer during the pandemic.⁴ Delayed mammography and computed tomography for lung cancer were associated with advanced stage of cancer at diagnosis.⁴ Another study determined delayed surgery for lung cancer was associated with worse survival.¹¹ For breast screenings, some evidence suggests that patients were reluctant to return for mammograms after care disruptions.¹² Thus, cancer care disruptions during COVID-19 could have detrimental future impacts on cancer outcomes and may require changes to public health and clinical strategies across the cancer prevention and control continuum.

It is unclear if patients felt comfortable returning to care in the context of rapidly changing information and guidelines related to COVID-19 and even now that guidelines are more consistent and vaccines are available. There is concern about whether patients will prioritize immediate unmet social needs that might be a result of or exacerbated by COVID-19, such as food insecurity, employment loss, and housing challenges, over disease prevention. Furthermore, people of color, including African Americans, Latinx, and Native communities, as well as those employed in low-wage occupations, are likely to have greater concerns over COVID-19 safety, in addition to the immediate concerns noted above.¹³ Rural communities that already experience limited access to cancer care, have less capacity to manage COVID-19.¹⁴ Finally, hospitals rapidly increased the use of telehealth to continue cancer care during COVID-19, but older people and those who lived in low-income and rural areas, or were less likely to have commercial insurance were less likely to participate.^15,16 This combination of factors may exacerbate existing disparities.¹³

This survey study was conducted by NCI-designated Siteman Cancer Center to elucidate: 1) to what extent cancer care appointments (including preventive screenings and treatment) in the bi-state Midwestern catchment area were postponed or canceled, 2) patients’ needs for returning to care, and 3) correlates of care disruption across the catchment area. The cancer burden is significantly greater in this catchment area than the US averages for multiple cancers. Moreover, racial and geographical disparities persist such that African American patients have higher incidence and mortality for lung, colorectal, late-stage breast cancer diagnoses, and prostate cancers compared to White patients. Rural counties also have higher mortality (but not incidence) for melanoma, breast, and prostate cancer compared to urban areas.¹⁷

Thus, we explore how socio-contextual factors impact cancer health disparities across the continuum of cancer control and prevention during COVID-19 in this bi-state Midwestern catchment area. Race, ethnicity, social class, and gender are social identities that shape many contextual factors related to cancer and COVID outcomes and are considered in this report. We stratify our results by race because of the differential impact of COVID-19 on communities of color and the over-representation of socioeconomic factors such as low-income, low-wage work often experienced by communities of color.^18-20

Methods

Results

Sociodemographic and care disruption descriptive information

Unadjusted sociodemographic characteristics of this sample of residents from the Siteman Cancer Center catchment area (n=680) are presented in Table 1. Residents were 46 years old on average. The diverse study sample included 41% respondents of color, and 28% of the respondents live in a non-metro area. The majority of residents identified as female (68%), lived in metro areas (73%), and had a 4-year college or graduate degree (38%). Compared to our catchment area, this sample had a higher proportion of women (68% vs. 51%) and college graduates (38% vs. 30%). We also had a higher proportion of people of color (41% vs. 21%) and residents who lived in rural areas (28% vs. 15%) due to intentional oversampling.

View this table:

• View inline
• View popup

Table 1.

Characteristics of residents across Missouri and Southern Illinois by care disruption status (July-August 2020).

In this sample, approximately 55% of respondents experienced disruption to their scheduled healthcare appointments. Those who experienced care disruption were more likely to be female and have higher levels of educational attainment compared to those who did not experience care disruption.

The number of residents scheduled for a cancer screening appointment, and whose appointment was postponed by the patient or their doctor/clinic is presented in Figure 1. There were 480 possible appointments scheduled between March 2020 through the end of 2020 for either a mammogram, pap test, blood stool test, colonoscopy, or PSA test. Appointment cancelations varied from 21%-57% by screening type. Additionally, in our sample, 25% of residents canceled a scheduled in-person dental appointment, 31% avoided seeking care in a hospital (e.g. labor and delivery, emergency room, etc.), and 46% of residents canceled a scheduled in-person general medical appointment (data not presented).

• Download figure
• Open in new tab

Figure 1.

Care Disruption by Cancer Screening/Appointment Type across Missouri and Southern Illinois (July-August 2020)

Figure footnotes: N shown is the number who were planning to have a screening test between March 2020 and the end of 2020; For Cancer-related care, this question was asked only of those who self-reported ever being diagnosed as having cancer and the number scheduled for the test is unknown

Discussion

Using primary data collected from residents across the 82-county Siteman catchment area in Missouri and Illinois, we learned that 21% to 57% of cancer screening or treatment appointments were canceled from March 2020 through the end of 2020. Across all races, residents with higher educational attainment had 1.25 higher odds of care disruption for general or cancer care compared to residents with lower educational attainment; this association remained significant among Black and White residents. Additionally, White residents of older age, assigned female at birth, or having scheduled a telehealth appointment, also had higher odds of care disruption. Finally, knowing their doctor’s office or clinic is taking the appropriate COVID-related safety precautions was the greatest reported need for returning to care (33.8%).

Delays in cancer screening can lead to stage shifts where patients are diagnosed at later stages and thus have a higher risk for cancer morbidity and mortality. Understanding which screenings were impacted and for whom and identifying patient concerns can inform community outreach and engagement efforts. This allows programs to target groups most likely to have delayed screening and draft messaging that can alleviate patient concerns and in turn facilitate a return to care.

Mammograms and Pap tests are an area of increased interest for our catchment area given the high number of women scheduled for screening. Approximately 38% of the 170 women who were scheduled for mammograms had delayed or canceled appointments. Similarly, 45% of the 188 women scheduled for Pap tests had delayed or canceled appointments. Delays in colorectal cancer screening impacted a smaller number of people, but colorectal cancer screening is an important area given the high proportion of cancellations, overall low number of scheduled appointments in general, and high colorectal cancer disparities in the region. Of the 51 people scheduled for a colonoscopy, 57% delayed or canceled appointments, and of the 38 scheduled for a blood stool test, 29% delayed or canceled appointments as well. To help healthcare systems reduce the cancer screening deficit, community outreach and engagement strategies need to address these needs. For example, employing mobile strategies such as the use of mobile mammography and home-based cervical and colorectal cancer screening tests could serve those most impacted.

These data are consistent with prior literature that suggests a reduction in general medical and cancer-related appointments.^2,5,7,30 This study allows us to understand the magnitude of the impact across Missouri and southern Illinois. Future research exploring whether those with higher educational attainment were more likely to cancel appointments because they were more likely to have better access to scheduling future appointments could further elucidate the extent of educational disparities in healthcare access.

These cross-sectional data cannot infer causality however, many of the correlates of interest (e.g., race, educational attainment) pre-date COVID-19 and the need to consider postponing clinical care. Thus, it is unlikely these results are subject to reverse causation. Also, those excluded due to missing data were more likely to be uninsured. If uninsured persons were also more likely to have postponed appointments, this could potentially bias results about care disruptions by insurance status towards the null and underestimating the impact.

Despite these limitations, this is a significant study that can improve our understanding of COVID-19 impacts on cancer prevention and control and offer specific insights into the region. In our data, those with higher education were more likely to postpone care. This indicates that any trends seen in increasing late-stage diagnosis might occur across socioeconomic categories. Additionally, while Black and White people of higher educational attainment both had increased odds of care disruption, having a scheduled telehealth visit was significantly associated with higher odds of care disruption only for White residents. This suggests that while White people were canceling in-person care, this care may have been substituted with telehealth appointments. Many of these screenings cannot be done virtually, yet this warrants further investigation to understand if care disruption does not always equate to being disconnected from healthcare for some and the subsequent impact on racial disparities in cancer care.